Filing status
- Accounts due
- 31 January 2028
- Last accounts
- 30 April 2026
- Conf. stmt due
- 1 April 2027
- Last conf. stmt
- 18 March 2026
Talisman Therapeutics Limited
- Incorporated
- 4 April 2013 (13 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Emily Anne ScraggsFrederick John LiveseyJonathan Mark Treherne
- Owned by
- Frederick John Livesey
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- Babraham HallBabraham Research CampusCambridgeCB22 3AT
Officers 3 active
Officer details are public data from the Companies House register.
Scraggs, Emily Anne, Dr
Director · Appointed 2 April 2014
Irish
Born November 1968
Livesey, Frederick John, Dr
Director · Appointed 4 April 2013
Irish
Born August 1969 (57)
Treherne, Jonathan Mark, Dr
Director · Appointed 4 April 2013
British
Born June 1961 (65)
Officer history (1 former)
20 September 2016
5 April 2014
2 April 2014
Appointed Scraggs, Emily Anne, Dr as Director
4 April 2013
Appointed Livesey, Frederick John, Dr as Director
4 April 2013
Appointed Treherne, Jonathan Mark, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Frederick John Livesey
Individual · Notified 6 April 2016
Owns 50–75% of shares
Holds 50–75% of voting rights
Right to appoint and remove directors
Irish
Born August 1969 (57)
Financials
Figures from 2025 accounts. Newer accounts, made up to 30 April 2026, are filed but not read yet. See them on Companies House
- Net Assets
- £641,237
- Cash
- £69
- Employees
- 15
- Debt Ratio
- 27%
- Current Ratio
- 3.1x
Balance sheet detail
| 2025 | |
|---|---|
| Fixed Assets | £149,899 |
| Current Assets | £728,076 |
| Cash | £69 |
| Creditors (< 1 year) | £234,337 |
| Net Current Assets | £493,739 |
| Net Assets | £641,237 |
| Shareholder Funds | £641,237 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 18 September 2026 | Statement of capital following an allotment of shares | |||
| 3 September 2026 | Total exemption full accounts | 30 April 2026 | ||
| 2 April 2026 | Confirmation statement with no updates | 18 March 2026 | ||
| 6 October 2025 | Total exemption full accounts | 30 April 2025 | ||
| 19 March 2025 | Confirmation statement with no updates | 18 March 2025 |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →